Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.

Source:http://linkedlifedata.com/resource/pubmed/id/3114506

JAMA 1987 Oct 2 258 13 1777-81

Download in:

View as

General Info

PMID
3114506